摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-(S)-alanine | 30037-41-3

中文名称
——
中文别名
——
英文名称
N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-(S)-alanine
英文别名
N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-(S)-phenylalanine;(S)-(-)-N-Benzoyl-3-(4-hydroxy-3-methoxyphenyl)alanin;D,L-N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-alanine;N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-alanine;(2S)-2-benzamido-3-(4-hydroxy-3-methoxyphenyl)propanoic acid
N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-(S)-alanine化学式
CAS
30037-41-3
化学式
C17H17NO5
mdl
——
分子量
315.326
InChiKey
ODTCNJWUFHCFJB-ZDUSSCGKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    95.9
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    新型手性双膦配体反式BIS-1,2-(二苯基膦基)环​​丁烷的合成与分离及其铑配合物的不对称氢化
    摘要:
    源自双-1,4-(二苯基膦基)丁烷的1,4-二碳负离子的氧化偶联得到(±)-反式-双-1,2-(二苯基膦基)环​​丁烷。使用通过还原分解的双膦氧化物获得的旋光双膦的铑络合物对脱氢氨基酸进行不对称氢化,以高光学产率提供氢化产物。
    DOI:
    10.1246/cl.1986.613
  • 作为产物:
    描述:
    2-(Benzoylamino)-3-(4-hydroxy-3-methoxyphenyl)acrylsaeure 在 <(2R,3R)-2,3-Bis(diphenylphosphino)butan>(ϖ-norbornadien)rhodium(I)-perchlorate 氢气 作用下, 以 四氢呋喃 为溶剂, 反应 8.0h, 以98%的产率得到N-benzoyl-3-(4-hydroxy-3-methoxyphenyl)-(S)-alanine
    参考文献:
    名称:
    Koettner, Johann; Greber, Gerd, Chemische Berichte, 1980, vol. 113, # 6, p. 2323 - 2325
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Process for the preparation of l-dopa
    申请人:Hoffmann-La Roche Inc.
    公开号:US03969397A1
    公开(公告)日:1976-07-13
    The present invention is directed to preparing L-Dopa, an agent effective in the treatment of Parkinson's Disease, from a D,L-N-benzoyl-3-(4-hydroxy-3-methoxyphenyl) alanine utilizing dehydroabietylamine as a resolving agent and intermediates in this process.
    本发明涉及利用去氢阿比特胺作为分离剂,从D,L-N-苯甲酰-3-(4-羟基-3-甲氧基苯基)丙氨酸制备对帕金森病治疗有效的L-多巴胺,并涉及该过程中的中间体。
  • Catalytic asymmetric hydrogenation
    申请人:Monsanto Company
    公开号:US04261919A1
    公开(公告)日:1981-04-14
    Process for the homogeneous catalytic hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids which yields, after hydrogenation, an optically active mixture. The process comprises the hydrogenation of .beta.-substituted-.alpha.-acylamidoacrylic acids in the presence of an optically active coordinated metal complex hydrogenation catalyst, in which the metal is selected from the group consisting of rhodium, iridium, ruthenium, osmium, palladium and platinum. This process is a generalized process for any asymmetric hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids in which one .alpha.-amino acid enantiomorph is the desired end-product. It is especially useful for the preparation of .alpha.-amino acids found in nature which possess optical activity and which have a hydrogen attached to the asymmetric center. This invention also relates to new optically active coordinated metal complex hydrogenation catalysts.
    .beta.-取代-.alpha.-酰胺基丙烯酸催化氢化的均相催化过程,氢化后产生一种光学活性混合物。该过程包括在光学活性配位金属复合物氢化催化剂的存在下,对.beta.-取代-.alpha.-酰胺基丙烯酸进行氢化,其中金属选自铑、铱、钌、锇、钯和铂的群。该过程是任何不对称氢化.beta.-取代-.alpha.-酰胺基丙烯酸的广义过程,其中一种.alpha.-氨基酸对映异构体是期望的最终产品。它特别适用于制备天然存在、具有光学活性并且在不对称中心附着氢的.alpha.-氨基酸。本发明还涉及新的光学活性配位金属复合物氢化催化剂。
  • Methylcyclohexyl-O-anisylphosphine
    申请人:Monsanto Company
    公开号:US04294989A1
    公开(公告)日:1981-10-13
    Process for the homogeneous catalytic hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids which yields, after hydrogenation, an optically active mixture. The process comprises the hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids in the presence of an optically active coordinated metal complex hydrogenation catalyst, in which the metal is selected from the group consisting of rhodium, iridium, ruthenium, osmium, palladium and platinum. This process is a generalized process for any asymmetric hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids in which one .alpha.-amino acid enantiomorph is the desired end-product. It is especially useful for the preparation of .alpha.-amino acids found in nature which possess optical activity and which have a hydrogen attached to the asymmetric center. This invention also relates to new optically active coordinated metal complex hydrogenation catalysts.
    .beta.-取代-.alpha.-酰胺基丙烯酸的均相催化氢化过程,氢化后产生一个光学活性混合物。该过程包括在光学活性配位金属催化剂的存在下,氢化.beta.-取代-.alpha.-酰胺基丙烯酸,其中金属选自铑、铱、钌、锇、钯和铂组成的一组。该过程是任何不对称氢化.beta.-取代-.alpha.-酰胺基丙烯酸的广义过程,其中一个.alpha.-氨基酸对映异构体是期望的最终产物。它特别适用于制备天然存在的具有光学活性并在不对称中心附有氢的.alpha.-氨基酸。本发明还涉及新的光学活性配位金属催化剂。
  • Metal coordination complexes containing optically active phosphine or
    申请人:Monsanto Company
    公开号:US04124533A1
    公开(公告)日:1978-11-07
    Process for the homogeneous catalytic hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids which yields, after hydrogenation, an optically active mixture. The process comprises the hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids in the presence of an optically active coordinated metal complex hydrogenation catalyst, in which the metal is selected from the group consisting of rhodium, iridium, ruthenium, osmium, palladium and platinum. This process is a generalized process for any asymmetric hydrogenation of .beta.-substituted-.alpha.-acylamido-acrylic acids in which one .alpha.-amino acid enantiomorph is the desired end-product. It is especially useful for the preparation of .alpha.-amino acids found in nature which possess optical activity and which have a hydrogen attached to the asymmetric center. This invention also relates to new optically active coordinated metal complex hydrogenation catalysts.
    .beta.-取代-.alpha.-酰胺基丙烯酸的均相催化氢化过程,经过氢化后,产生一个旋光性混合物。该过程包括在旋光性配位金属复合催化剂的存在下进行.beta.-取代-.alpha.-酰胺基丙烯酸的氢化,其中金属选自铑、铱、钌、锇、钯和铂的群体。该过程是用于任何不对称氢化的.beta.-取代-.alpha.-酰胺基丙烯酸的广义过程,其中一个.alpha.-氨基酸对映异构体是期望的最终产物。它特别适用于制备在自然界中发现的具有光学活性并且在不对称中心处有氢的.alpha.-氨基酸。本发明还涉及新的旋光性配位金属复合催化剂。
  • Synthesis of 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), an atropisomeric chiral bis(triaryl)phosphine, and its use in the rhodium(I)-catalyzed asymmetric hydrogenation of .alpha.-(acylamino)acrylic acids
    作者:A. Miyashita、A. Yasuda、H. Takaya、K. Toriumi、T. Ito、T. Souchi、R. Noyori
    DOI:10.1021/ja00547a020
    日期:1980.12
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物